Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...

The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest ...

Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first ...

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...

Key Takeaways Moderna shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you ...

The first bird-flu fatality in the United States sparks investor interest in several vaccine makers that are developing ...

We don’t have answers for all the deadly infectious diseases in the world, a fact made painfully clear Monday as Louisiana ...

Shares of Moderna (MRNA), one of a few drugmakers currently developing a vaccine for the H5N1 bird flu, were up nearly 10% in early trading ...

Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.